GGrantIndex
← Search

NOVEL OXABOROLE ANALOGS FOR TREATMENT OF CUTANEOUS LEISHMANIASIS

$473,020FY2014Department of the ArmyDOD

Anacor Pharmaceuticals, Inc., Palo Alto CA

Investigators

View source on USAspending →
NOVEL OXABOROLE ANALOGS FOR TREATMENT OF CUTANEOUS LEISHMANIASIS · GrantIndex